Generic Name: Linagliptin 2.50mg + Metformin Hydrochloride 500mg
Company Name: Nipro JMI Pharma Ltd
🛒 How to order this item?
100% Genunie Product
Safe & Secure Payment
Secure & Effecient Delivery
Proper Packaging
Show More
Indications
Lijenta-M 500 is a combination of two medications that helps people with type 2 diabetes mellitus manage their high blood sugar levels. This lessens your risk of developing serious diabetes complications like kidney damage and blindness and lowers your risk of a heart attack or stroke. It is possible to prescribe Lijenta-M 500 alone or in combination with other diabetes drugs.
Pharmacology
The incretin hormones GLP-1 (glucagon-like peptide-1) and GIP are degraded by the enzyme DPP-4, which is inhibited by linagliptin (glucose-dependent insulinotropic polypeptide). By stimulating the release of insulin from pancreatic beta () cells in a glucose-dependent manner and inhibiting the release of glucagon from pancreatic alpha () cells into circulation, linagliptin raises the concentrations of active incretin hormones.
A biguanide-type oral antihyperglycemic medication called metformin hydrochloride is used to treat type 2 diabetes. It lowers plasma glucose at rest and after eating. It does not cause hypoglycemia and has a different mechanism of action from sulfonylureas. By increasing peripheral glucose uptake and utilization, metformin hydrochloride reduces hepatic glucose production, intestinal glucose absorption, and insulin sensitivity.
Dosage & Administration
Depending on the effectiveness and tolerability of the medication, the dosage of Linagliptin & Metformin immediate-release tablets should be customized. Linagliptin 2.5 mg at a maximum recommended dose of 1000 mg of metformin hydrochloride taken twice daily with meals. To minimize the gastrointestinal (GI) side effects related to the use of metformin hydrochloride, dose escalation should be gradual.
Starting with 500 mg of Metformin Hydrochloride and 2.5 mg of Linagliptin twice daily is advised for patients who are not currently receiving Metformin Hydrochloride treatment.
Start with 2.5 mg of Linagliptin and the usual dosage of Metformin Hydrochloride twice daily in patients who are already receiving this medication.
Individual components may be switched to this combination, which contains the same doses of each component, for patients already receiving treatment with Linagliptin and Metformin Hydrochloride.
Interactions
Cationic drugs (amiloride, digoxin, morphine, ranitidine, trimethoprim, etc.): May reduce metformin elimination.
P-glycoprotein/CYP3A4 inducer (i.e. rifampin): The efficacy of this medicine may be reduced when administered in combination.
Contraindications
Linagliptin has a very low renal excretion rate, whereas metformin hydrochloride is known to have a high renal excretion rate. With the severity of renal impairment, the risk of Metformin Hydrochloride accumulation and lactic acidosis rises. Therefore, patients with renal impairment should not take this combination. Acute or chronic metabolic acidosis (diabetic ketoacidosis) and hypersensitivity to linagliptin or metformin hydrochloride are also contraindications.
Side-Effects
The most common side effects are nasopharyngitis and diarrhea. Hypoglycemia is more common in patients treated with this combination and sulfonylureas.
Pregnancy & Lactation
There are no adequate and well-controlled studies in pregnant women with this combination or its individual component; so, it should be used during pregnancy only if clearly needed. Caution should also be exercised when it is administered to a lactating mother.
Precautions
Storage Conditions
Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.